Production (Stage)
Bone Biologics Corporation
BBLG
$5.08
$0.142.83%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.75M | 3.33M | 3.57M | 2.33M | 3.23M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 206.50K | 278.20K | 113.70K | 211.10K | 283.10K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 209.00K | 258.10K | 385.70K | 650.30K | 328.80K |
| Total Current Assets | 3.16M | 3.86M | 4.07M | 3.19M | 3.84M |
|
|
|||||
| Total Current Assets | 3.16M | 3.86M | 4.07M | 3.19M | 3.84M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 3.16M | 3.86M | 4.07M | 3.19M | 3.84M |
|
|
|||||
| Total Accounts Payable | 247.80K | 373.00K | 190.10K | 231.90K | 146.20K |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 3.30K | 4.70K | 83.30K | 52.60K | 18.40K |
| Total Other Current Liabilities | 3.30K | 4.70K | 83.30K | 52.60K | 18.40K |
| Total Current Liabilities | 251.20K | 377.70K | 273.40K | 284.50K | 164.60K |
|
|
|||||
| Total Current Liabilities | 251.20K | 377.70K | 273.40K | 284.50K | 164.60K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 251.20K | 377.70K | 273.40K | 284.50K | 164.60K |
|
|
|||||
| Common Stock & APIC | 88.95M | 88.51M | 87.29M | 85.47M | 85.45M |
| Retained Earnings | -86.04M | -85.02M | -83.50M | -82.56M | -81.77M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 2.91M | 3.48M | 3.79M | 2.91M | 3.67M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.91M | 3.48M | 3.79M | 2.91M | 3.67M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.91M | 3.48M | 3.79M | 2.91M | 3.67M |
|
|
|||||